Conduent Applies GenAI to Revolutionize Detection of Reportable Events and Sets New Standard for FDA Compliance

Conduent Incorporated (Nasdaq: CNDT), a global technology-driven business solutions and services company, announced the launch of a new generative AI-powered platform designed to enhance the identification of reportable events. The initiative establishes a new benchmark for FDA compliance and regulatory efficiency.

AI-Powered Innovation

Developed in collaboration with Microsoft Azure OpenAI, the solution automates the detection and classification of reportable events for pharmaceutical and life sciences organizations. It operates across multiple customer touchpoints, significantly improving accuracy and reducing time-to-report.

“Our GenAI technology streamlines complex compliance processes, allowing teams to identify and address reportable events more quickly and precisely,” said Sean Collins, Media Relations at Conduent.

Industry Impact

By integrating generative AI with regulatory data and machine learning workflows, Conduent aims to redefine industry standards for compliance monitoring. This approach not only ensures greater accuracy but also enhances transparency and accountability in FDA-subject reporting processes.

Contacts

Media: Sean Collins, Conduent, +1-310-497-9205, [email protected]
Investor Relations: Joshua Overholt, Conduent, [email protected]

Author’s Summary: Conduent’s new AI-driven platform sets a fresh compliance standard, enabling faster, more accurate detection of reportable events in pharma and life sciences.

Business Wire — 2025-11-05